Quant Mutual Fund Pharma Fund - Regular Plan - Growth ke returns – 1, 3, 5 saal ke aankde
Ab baat karte hain is fund ke returns ki. 1 saal me is fund ne sirf 0.18% ka return diya hai, jo ki thoda disappointing hai jab hum isse Nifty Pharma TRI benchmark se compare karte hain. Lekin, 3 saal ki duration me iska return 8.67% hai, jo ki thoda better hai. Aur agar hum 5 saal ke performance ki baat kare, to ye fund 7.6% ka return de raha hai.
Kya aapne socha hai ki yeh returns consistent hain ya nahi? Dekho, jab hum is fund ki volatility ki baat karte hain, to iski riskometer rating "Very High" hai, iska matlab hai ki is fund me investment karna un logon ke liye hai jo high risk tolerate kar sakte hain. Is fund ke returns me market volatility ka bhi impact hota hai.
Fund manager ka role bhi yahan important hai, lekin unfortunately, current data me fund manager ka naam nahi hai. Aam taur pe, fund manager ki expertise kaafi important hoti hai performance ko impact karne ke liye. Toh, yahan pe aapko thoda soch samajh kar hi entry leni chahiye.
Quant Mutual Fund Pharma Fund - Regular Plan - Growth portfolio breakdown for investors
Is fund ki portfolio ka structure bhi kaafi important hai. Top 5 holdings me aapko Sun Pharmaceutical Industries Ltd. (20.5%), Dr. Reddy's Laboratories Ltd. (12.8%), Cipla Ltd. (10.4%), Divi's Laboratories Ltd. (9.8%), aur Torrent Pharmaceuticals Ltd. (7.2%) dikhai dete hain.
Ye holdings is fund ki investment strategy ko reflect karte hain jo ki pharmaceutical sector ki top companies pe focus karte hain. Iska matlab hai ki agar aap pharma sector me invest karte hain, to aapko in companies ki growth ka benefit mil sakta hai.
Sector allocation bhi kaafi zaroori hai; agar aap dekhenge to yeh fund puri tarah se pharma sector me concentrated hai, jo ki ek taraf to high growth potential offer karta hai, lekin doosri taraf se iski diversity thodi kam hai. Agar aapko portfolio diversification ki zarurat hai, to aapko is fund me invest karne se pehle achhe se sochna hoga.
Quant Mutual Fund Pharma Fund - Regular Plan - Growth risk analysis and volatility
Jab hum is fund ki risk analysis ki baat karte hain, to iski riskometer rating "Very High" hai, jo ki is fund ke liye appropriate hai. Agar aapko high volatility se koi dikkat nahi hai aur aap long-term investment ke liye ready hain, to yeh fund aapke liye sahi ho sakta hai.
Fund ki volatility ko samajhna bhi zaroori hai, kyunki high volatility ka matlab hai ki fund ke returns me ups and downs aane wale hain. Is fund ne historically kuch fluctuations dekhe hain jo ki pharma sector ki nature se bhi linked hain. Agar aap risk-tolerant investor hain, to yeh fund aapke risk profile ke liye suitable hai.